Last reviewed · How we verify
NCT03755635
Neonatal Sepsis at Neonatal Intensive Care Units in Ghana
NA trial testing The WHO multimodal hand hygiene strategy in Neonatal SEPSIS in 5,433 participants. Completed in 30 September 2019.
30 September 2019
Quick facts
| Lead sponsor | Stephanie Bjerrum |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 5,433 |
| Start date | 1 October 2018 |
| Primary completion | 30 September 2019 |
| Estimated completion | 30 September 2019 |
| Sites | 1 location across Ghana |
Drugs / interventions tested
- The WHO multimodal hand hygiene strategy
Conditions studied
- Neonatal SEPSIS — all drugs for Neonatal SEPSIS →
Sponsor
Stephanie Bjerrum
Who can join
Adults 1 Minute to 48 Hours, any sex, with Neonatal SEPSIS. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Neonatal sepsis is a major contributor to global under five mortality. In developing countries a major proportion of neonatal sepsis is thought to emanate from the healthcare setting, due to challenges in infection prevention practices. Aim: To study the epidemiology of neonatal sepsis and evaluate the effect of multimodal infection control interventions on the incidence of neonatal sepsis; and colonization by multidrug resistant Gram negative bacteria (MDRGNB). Methods: A controlled before and after interventional trial comprising a 7 month pre- intervention phase, 5 month intervention phase and 7 month post-intervention phase. Neonates admitted at the Neonatal Intensive Care Unit (NICU) at Korle-Bu Teaching Hospital (KBTH) will be enrolled prospectively and followed up for diagnosis of sepsis and outcome of admission. This will be used to describe the epidemiology of neonatal sepsis. Swabs will be collected from a subpopulation of included neonates at intervention site (KBTH) and control site (37 Military Hospital) NICUs to assess colonization of neonates with MDRGNB. Environmental swabs will be collected from surfaces at the NICU to assess MDRGNB contamination of the environment. The intervention comprises infection prevention strategies including implementation of the WHO multimodal hand hygiene strategy. The primary endpoint is incidence of neonatal sepsis. Expected Outcome: This study will contribute to improved infection prevention practices in the participating NICUs and highlight lessons which other national and regional NICUs may learn from.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
High Carriage Rates of Multidrug-Resistant Gram-Negative Bacteria in Neonatal Intensive Care Units From Ghana.
Labi AK, Bjerrum S, Enweronu-Laryea CC, Ayibor PK, et al · · 2020 · cited 37× · PMID 32373647 · DOI 10.1093/ofid/ofaa109 -
Hand hygiene for the prevention of infections in neonates.
Kuti BP, Ogunlesi TA, Oduwole O, Oringanje CC, et al · · 2023 · cited 5× · PMID 37278689 · DOI 10.1002/14651858.cd013326.pub4 -
Hand hygiene for the prevention of infections in neonates.
Kuti BP, Ogunlesi TA, Oduwole O, Oringanje C, et al · · 2021 · cited 4× · PMID 33471367 · DOI 10.1002/14651858.cd013326.pub2
Verify or expand the search:
- PubMed search for NCT03755635
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neonatal SEPSIS
Currently open trials in the same condition.
- NCT03291496 — Microfluidic Assessment of Clinical Outcomes in Preterm Newborns · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03755635 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stephanie Bjerrum
- Last refreshed: 11 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03755635.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing